trinitrobenzenesulfonic acid has been researched along with Wasting Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fortin, G; Franchimont, D; Gautier, P; Raymond, M; Rubio, M; Sarfati, M; Van, VQ | 1 |
| Abad, C; Arranz, A; Delgado, M; Gomariz, RP; Juarranz, MG; Leceta, J; Martinez, C | 1 |
| Arimura, Y; Goto, A; Hinoda, Y; Imai, K; Shinomura, Y | 1 |
| Drillenburg, P; Peppelenbosch, MP; Pronk, I; ten Hove, T; van den Blink, B; van Deventer, SJ | 1 |
4 other study(ies) available for trinitrobenzenesulfonic acid and Wasting Disease
| Article | Year |
|---|---|
A role for CD47 in the development of experimental colitis mediated by SIRPalpha+CD103- dendritic cells.
Topics: Animals; Antigens, CD; CD47 Antigen; Colitis; Dendritic Cells; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Integrin alpha Chains; Lymph Nodes; Mice; Mice, Inbred BALB C; Mice, Knockout; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; Trinitrobenzenesulfonic Acid; Wasting Syndrome | 2009 |
Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
Topics: Animals; Colitis; Crohn Disease; Cytokines; Disease Models, Animal; Down-Regulation; Gastrointestinal Agents; Male; Mice; Mice, Inbred BALB C; Receptors, Vasoactive Intestinal Peptide; Receptors, Vasoactive Intestinal Polypeptide, Type I; Th1 Cells; Th2 Cells; Trinitrobenzenesulfonic Acid; Vasoactive Intestinal Peptide; Wasting Syndrome | 2003 |
Antisense therapy of MAdCAM-1 for trinitrobenzenesulfonic acid-induced murine colitis.
Topics: Animals; B-Lymphocytes; Cell Adhesion Molecules; Cell Line; Colitis; Colon; Endothelial Cells; Feasibility Studies; Mice; Mice, Inbred BALB C; Mucoproteins; Oligonucleotides; Oligonucleotides, Antisense; RNA, Messenger; Trinitrobenzenesulfonic Acid; Wasting Syndrome | 2006 |
Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitis.
Topics: Animals; Blotting, Western; Colitis; Enzyme Activation; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Imidazoles; Interferon-gamma; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pyridines; T-Lymphocytes; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha; Wasting Syndrome; Weight Loss | 2002 |